SI
NXTM

Stephens Inc’s NxStage Medical Inc. NXTM Stock Holding History

Stephens Inc’s Portfolio NXTM Stock Details NXTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-18,300
Closed -$261K – 852
2013
Q2 		$261K Buy
+18,300
New +$230K 0.01% 567

Other funds holding NXTM

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Stephens Inc's NXTM Position: Q3 2013 in Review

Stephens Inc sold out of NxStage Medical Inc. (NXTM) in Q3 2013, closing a stake of 18,300 shares — an estimated $261K sold.

Stephens Inc first reported a position in NXTM in Q2 2013 and held it in 1 quarter. The position peaked at $261K in Q2 2013. 115 funds tracked by Wall St. Rank hold NXTM as of Q3 2013.

  • Stephens Inc reported no remaining NxStage Medical Inc. position as of Q3 2013 after selling out during the quarter.
  • Stephens Inc sold 18,300 NxStage Medical Inc. shares in Q3 2013, an estimated $261K.
  • Stephens Inc first reported a position in NxStage Medical Inc. in Q2 2013 and held it in 1 quarter.
  • Stephens Inc's NxStage Medical Inc. position peaked at $261K in Q2 2013.
  • 115 funds tracked by Wall St. Rank held NxStage Medical Inc. as of Q3 2013.

Based on Stephens Inc's 13F filing for Q3 2013, filed 6 Nov 2013.